GoSTEMChamps! Speaker Series: Journey of a Virus Hunter

Discover. Create. Invent. We are here to support you in your STEM journey!

Powered by Abbott and UWS, GoSTEMChamps! presents the first STEM Speaker Series for 2022: Journey of a Virus Hunter.

Join us to hear from Mary Rodgers, Ph.D., Principal Research Scientist at Abbott about her adventures with tiny, virulent viruses and stand a chance to win attractive prizes during the session and a chance to join our internship program!

Register through the QR Code below or click the link below to sign up!


Date: Saturday, 7 May 2022

Time: 9:00 – 10.15 AM

Registration link: https://bit.ly/3rBkMd0


About GoSTEMChamps!

GoSTEMChamps! has been co-created by Abbott and UWS to inspire and support the next generation of STEM leaders in Singapore.

Science, Technology, Engineering and Mathematics (STEM) solve many of the world’s problems and have an outsized impact on our daily lives. Abbott is a global health technology company with a longstanding commitment in STEM education (Learn about Abbott’s other STEM initiatives here).United Women Singapore (UWS) is a non-profit organisation that advances women’s empowerment and gender equality. Its flagship STEM programme, Girls2Pioneers aims to motivate girls and young women to take up STEM subjects in their higher education and careers to create a more gender equal society.

Both organisations share a common mission – to support youth in their pursuit of careers in STEM fields.

Through GoSTEMChamps!, youth in Singapore will have the opportunity to engage with leading scientists, engineers and health technologists who will showcase the vast possibilities in STEM fields. The students who sign up for and attend the programme will also stand to participate in internships with Abbott.

In the first webinar of the GoSTEMChamps! STEM Speaker Series we feature Mary Rodgers, Principal Research Scientist at Abbott.

More details in the poster above. Hurry! Register today.


About Mary A. Rodgers, PhD:

Mary A. Rodgers

As a principal research scientist in Abbott’s diagnostics business, Mary Rodgers manages the Abbott Global Viral Surveillance Program and external collaborations for the infectious disease research division.

Abbott’s Global Surveillance Program was established more than two decades ago to detect and actively monitor emerging HIV and hepatitis strains around the world. By monitoring the diversity of current epidemics as well as the next public health threats, this program serves as the scientific foundation upon which Abbott’s diagnostic tests are built.

In 2020, Mary was part of the team that developed Abbott’s COVID-19 tests and has since added SARS-CoV-2 to the Surveillance program. To date, Mary’s team has analyzed over 3 million SARS-CoV-2 variant sequences.

In 2019, Mary and a team of Abbott scientists announced the discovery of a new subtype of HIV and made the sequence available to the global research community. This research marked the first time in 19 years that a new subtype of HIV-1 Group M has been identified.

Mary received her Ph.D. in biological and biomedical sciences from Harvard University. She completed her postdoctoral training at the University of Southern California.  Mary joined Abbott in 2014 and has since added two new pathogens (HCV, HDV) to the Surveillance Program, published 12 research papers, and was  named one of Business Insider’s 30 under 40                Young Leaders in Biotech in 2017.

Mary is a member of the American Association for the Advancement of Science and the American Society of Microbiology.